ArticleEye (London, England)2022

Type one macular neovascularization in central serous chorioretinopathy: Short-term response to anti-vascular endothelial growth factor therapy.

Raphaël Lejoyeux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.